Michael Gameng

Michael Gameng has a diverse and extensive work experience in the biopharmaceutical industry. Michael has held various roles at different companies, including Alumis, BiotechCIO, Protagonist Therapeutics, Bristol Myers Squibb, MyoKardia (Acquired by Bristol Myers Squibb), Relypsa (Acquired by Vifor Pharma), Jazz Pharmaceuticals, InterMune (Acquired by Genentech/Roche), and Onyx Pharmaceuticals (a wholly-owned subsidiary of Amgen). Their roles have included Director, R&D Business Partner; Member; Director, IT Business Partner, GxP Systems; Associate Director, Clinical Development IT Business Partner; Senior Manager, GxP Systems; Application Support Manager, IT-R&D (Contractor); Senior Business Analyst, GxP Applications; Manager, IT – Research & Development Applications; Validated Applications Administrator; System Validation Analyst; and Network System Administrator II. Michael has been responsible for various tasks and responsibilities such as overseeing IT vendors and business partnerships, establishing IT computer system validation programs, implementing software systems, and ensuring compliance with regulatory regulations.

Michael Gameng attended San Jose State University from 1997 to 2003, where they obtained a degree in Business with a focus on Management Information Systems.